Lunai Bioworks
LNAI
39 hedge funds and large institutions have $24.8M invested in Lunai Bioworks in 2024 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 19 closing their positions.
1,050% more call options, than puts
Call options by funds: $69K | Put options by funds: $6K
38% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 8
29% more capital invested
Capital invested by funds: $19.2M → $24.8M (+$5.58M)
0.06% more ownership
Funds ownership: 0.06% → 0.12% (+0.06%)
5% less funds holding
Funds holding: 41 → 39 (-2)
11% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$5.7M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.94M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.2M |
| 4 |
State Street
Boston,
Massachusetts
|
+$2.01M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$371K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$778K |
| 2 |
Goldman Sachs
New York
|
-$421K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$303K |
| 4 |
Citigroup
New York
|
-$291K |
| 5 |
Man Group
London,
United Kingdom
|
-$286K |
LNAI Hedge Fund Activity: Q2 2024 in Review
39 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Lunai Bioworks (LNAI) for Q2 2024, worth a combined $24.8M — up 29% from $19.2M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of LNAI and 17 opened new positions — a net loss of 2 holders — while 8 trimmed existing stakes and 11 added.
The largest buyer was BlackRock, adding an estimated $5.7M. The largest seller was Millennium Management, exiting entirely with an estimated $778K sold.
- 39 institutional investors held Lunai Bioworks (LNAI) as of Q2 2024, down from 41 in Q1 2024.
- Funds reported $24.8M of Lunai Bioworks stock for Q2 2024, up 29% quarter-over-quarter.
- 17 funds opened new Lunai Bioworks positions in Q2 2024 and 19 closed out, a net change of -2 holders.
- The largest Lunai Bioworks buyer in Q2 2024 was BlackRock, an estimated $5.7M added.
- The largest Lunai Bioworks seller in Q2 2024 was Millennium Management, an estimated $778K sold.
Based on aggregated 13F filings for Q2 2024.